Patient-Reported Outcomes and Quality of Life Improved with Fluticasone Propionate and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhalers Versus Placebo in Patients with Persistent Asthma

Methods This phase 3, double-blind, parallel-group study (FSS-AS-301; NCT02139644) evaluated asthmatic patients (ages >=12 years) using inhaled corticosteroids (ICS) or ICS/long-acting beta2-agonists.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2017-02, Vol.139 (2), p.AB10-AB10
Main Authors: Raphael, Gordon, MD, Yiu, Gloria, MS, Sakov, Anat, PhD, Liu, Siyu, MD, PhD, Caracta, Cynthia, MD, FCCP
Format: Article
Language:English
Subjects:
Allergy and Immunology
Asthma
Patients
Prescription drugs
Quality of life
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods This phase 3, double-blind, parallel-group study (FSS-AS-301; NCT02139644) evaluated asthmatic patients (ages >=12 years) using inhaled corticosteroids (ICS) or ICS/long-acting beta2-agonists.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2016.12.086